Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody-mediated Rejection in Kidney Transplant”

68 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 68 results

Large-scale testing (Phase 3)Enrolling By InvitationNCT07444489
What this trial is testing

Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) or Microvascular Inflammation (MVI) (TRANSCEND/TRANSPIRE LTE)

Who this might be right for
Antibody-mediated RejectionMicrovascular Inflammation
Biogen 201
Testing effectiveness (Phase 2)Study completedNCT00670774
What this trial is testing

Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney Transplant

Who this might be right for
Kidney Transplant
Mark Stegall 31
Not applicableStudy completedNCT05452317
What this trial is testing

Assess Burden of Disease Among Kidney Transplant Recipients With Chronic Active Antibody Mediated Rejection

Who this might be right for
Antibody-mediated Rejection in Kidney Transplant
CSL Behring 52
Testing effectiveness (Phase 2)Study completedNCT04046549
What this trial is testing

Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant

Who this might be right for
AllograftsRejection; Transplant, KidneyTransplant Rejection+1 more
Amgen 25
Not applicableActive Not RecruitingNCT07316829
What this trial is testing

TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiS

Who this might be right for
Graft RejectionKidney TransplantationLung Transplantation+6 more
Fondazione IRCCS Policlinico San Matteo di Pavia 30
Testing effectiveness (Phase 2)Study completedNCT05021484
What this trial is testing

Felzartamab in Late Antibody-Mediated Rejection

Who this might be right for
Antibody-mediated Rejection
Farsad Eskandary 22
Not applicableEnded earlyNCT03585855
What this trial is testing

Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Antibody Mediated Kidney Graft Rejection (ABMR)

Who this might be right for
Interventional
University Medical Centre Ljubljana 4
Not applicableStudy completedNCT03719339
What this trial is testing

VIRTUUS Children's Study

Who this might be right for
Renal Transplant RejectionPediatric Kidney DiseaseEnd Stage Renal Disease+4 more
Children's Hospital of Philadelphia 445
Testing effectiveness (Phase 2)Active Not RecruitingNCT05156710
What this trial is testing

BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)

Who this might be right for
Transplant Rejection
Sanofi 48
Large-scale testing (Phase 3)Active Not RecruitingNCT06685757
What this trial is testing

Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR)

Who this might be right for
Antibody-mediated Rejection
Biogen 132
Testing effectiveness (Phase 2)Active Not RecruitingNCT06503731
What this trial is testing

Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection (AMR)

Who this might be right for
Antibody-mediated Rejection
argenx 33
Not applicableActive Not RecruitingNCT03859388
What this trial is testing

Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection

Who this might be right for
Rejection Chronic RenalKidney Transplant Rejection
Cedars-Sinai Medical Center 10
Large-scale testing (Phase 3)Active Not RecruitingNCT04561986
What this trial is testing

TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients

Who this might be right for
Antibody-mediated Rejection
Vastra Gotaland Region 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07764627
What this trial is testing

Study of SG301 for Renal AMR After Transplantation

Who this might be right for
Antibody Mediated Rejection
Hangzhou Sumgen Biotech Co., Ltd. 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03380962
What this trial is testing

Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant

Who this might be right for
Kidney Failure, ChronicEnd-Stage Renal DiseaseTransplant Glomerulopathy+4 more
Stanley Jordan, MD 20
Testing effectiveness (Phase 2)Study completedNCT03444103
What this trial is testing

A Pilot Trial of Clazakizumab in Late ABMR

Who this might be right for
Antibody-mediated Rejection
Medical University of Vienna 20
Testing effectiveness (Phase 2)WithdrawnNCT01035593
What this trial is testing

Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation

Who this might be right for
Graft RejectionKidney Transplantation
Pharming Technologies B.V.
Not applicableStudy completedNCT03098238
What this trial is testing

Endothelial Microparticules and Antibody Mediated Rejection and Kidney Transplantation: Biomarker of Antibody-mediated Rejection in Kidney Transplantation

Who this might be right for
Renal Transplantation
University Hospital, Montpellier 249
Not applicableUnknownNCT05779124
What this trial is testing

BAFF/APRIL in Kidney Transplant Rejection Risk Assessment

Who this might be right for
Kidney TransplantationKidney Transplant Rejection
First Affiliated Hospital, Sun Yat-Sen University 176
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07613359
What this trial is testing

Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant

Who this might be right for
Antibody-Mediated Rejection (AMR)
Takeda 36
Next Page